What is Eloralintide?

What its clinical trials investigate, and what we do not yet know.

Updated 16 Nov 2026

Eloralintide is an experimental medicine in clinical trials. Researchers are studying a hormone signal called amylin. A trial is not a medicine approval.

At a glance

What it is
Investigational medicine
Research
Clinical trials; check the registry for current status
Areas studied
Clinical researchAmylin signallingBody weight
Current status
Trial registration is not medicine approval

Explore the research

What is Eloralintide?

Eloralintide is being investigated as a medicine affecting a signal called amylin. Amylin is a hormone involved in how the body responds to food. Researchers are testing whether changing that signal affects body weight and other measures. It works differently from substances targeting GLP-1, so the results cannot simply be treated as interchangeable.

What trials study

Registered trials describe who can take part and what researchers plan to measure. A trial record is a research plan or report, not proof of approval or a benefit for everybody. Read the registered eloralintide study and check the HPRA register separately for current Irish approval status.

Unanswered questions

Questions remain about longer-term outcomes, side effects and which people might benefit. Even when a study reports results, they concern the exact medicine tested in that trial, not a different laboratory material. A research result is not an instruction to use an experimental substance.

Comparing research

Both names appear in weight-related research, but they target different signals and may be studied in different groups. Comparing headlines cannot show which is safer or more effective. Ask a qualified healthcare professional about personal medical questions.

Common questions

What is Eloralintide being studied for?

Researchers investigate body weight and related measures in clinical trials of a specific experimental medicine.

Is Eloralintide approved in Ireland?

Do not infer approval from a trial listing. Check the HPRA register for current authorised-product information.

How do they compare?

Eloralintide and retatrutide investigate different body signals. That does not show either is better, safer or suitable for a person.

Known side effects?

Researchers assess safety during clinical trials; the evidence may change. Trial observations cannot establish the safety of a separately supplied material.

What is amylin?

It is a hormone involved in the body's response to food. Eloralintide research explores this signalling route.

Do trial results apply to other products?

No. Trial results concern the particular medicine studied, not another product supplied independently.

For research use only.

Our products are supplied for laboratory and in-vitro research and are not intended for human or veterinary use. By ordering, you confirm you're a qualified researcher and will handle the material responsibly.